avicorelogo.png
VANC Receives Recommendation from Glass Lewis
September 07, 2017 18:56 ET | VANC Pharmaceuticals
VANCOUVER, British Columbia, Sept. 07, 2017 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (the “VANC” or the “Company”) (TSX-V:VANC) (OTCQB:NUVPF), a pharmaceutical company focused on the Canadian...
avicorelogo.png
VANC Pharmaceuticals Announces Provincial Formulary Approvals for Atlantic Canada
September 06, 2017 15:29 ET | VANC Pharmaceuticals
VANCOUVER, British Columbia, Sept. 06, 2017 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (“VANC” or the “Company”) (TSX-V:VANC) (OTCQB:NUVPF), a pharmaceutical company focused on the Canadian...
avicorelogo.png
VANC Pharmaceuticals Receives Updated Health Canada Approval for Hema-Fer with New Indication for Use in Pregnancy
August 24, 2017 18:27 ET | VANC Pharmaceuticals
VANCOUVER, British Columbia, Aug. 24, 2017 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (“VANC” or the “Company”) (TSXV:VANC) (OTCQB:NUVPF), a pharmaceutical company focused on the Canadian generic...
avicorelogo.png
VANC Delivers Proxy Circular
August 22, 2017 17:29 ET | VANC Pharmaceuticals
VANCOUVER, British Columbia, Aug. 22, 2017 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. ("VANC") announced today that it has filed and mailed its notice of meeting and management information...
avicorelogo.png
VANC Pharmaceuticals Appoints Mr. Sherif Guorgui To Board of Directors
August 15, 2017 16:15 ET | VANC Pharmaceuticals
VANCOUVER, British Columbia, Aug. 15, 2017 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (TSXV:VANC) (OTCQB:NUVPF) (“VANC” or the “Company”), a pharmaceutical company focused on the Canadian generic...
avicorelogo.png
VANC Pharmaceuticals Closed First Tranche of Non Brokered Private Placement
August 04, 2017 18:01 ET | VANC Pharmaceuticals
VANCOUVER, British Columbia, Aug. 04, 2017 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (TSXV:VANC) (OTCQB:NUVPF) (“VANC” or the “Company”), a pharmaceutical company focused on the Canadian generic...
avicorelogo.png
VANC Pharmaceuticals Provides Corporate Update
August 01, 2017 20:07 ET | VANC Pharmaceuticals
VANCOUVER, British Columbia, Aug. 01, 2017 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (TSX-V:VANC) (OTCQB:NUVPF) (“VANC” or the “Company”), a pharmaceutical company focused on the Canadian...
VANC Pharmaceuticals Announces Hiring of Director of Pharmacy Solutions
July 24, 2017 12:20 ET | VANC Pharmaceuticals
VANCOUVER, British Columbia, July 24, 2017 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (“VANC” or the “Company”) (TSXV:VANC) (OTCQB:NUVPF), a pharmaceutical company focused on the Canadian generic...
VANC Pharmaceuticals Announces Non Brokered Private Placement
July 20, 2017 17:45 ET | VANC Pharmaceuticals
VANCOUVER, British Columbia, July 20, 2017 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (“VANC” or the “Company”) (TSXV:VANC) (OTCQB:NUVPF), a pharmaceutical company focused on the Canadian generic...
VANC Files Notice of Civil Claim Against Mo Aziz and Canagen
July 19, 2017 17:35 ET | VANC Pharmaceuticals
VANCOUVER, British Columbia, July 19, 2017 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. ("VANC") (TSXV:VANC) (OTCQB:NUVPF), announced today that it has filed a Notice of Civil Claim in the Supreme...